October 8th, 2012
Selections from Richard Lehman’s Literature Review: October 8th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include beta-blockers and the lack of a cardioprotective effect for certain patients; intra-aortic balloon support for MI with cardiogenic shock; prasugrel vs. clopidogrel for acute coronary syndromes without revascularization; CRP, fibrinogen, and CVD prediction; and a comparison of thrombectomy devices for acute ischemic stroke.
October 3rd, 2012
CRP and Cholesterol Emerge as Equally Strong Predictors of Cardiovascular Risk
Paul Ridker, MD, MPH
Paul Ridker discusses findings from the Emerging Risk Factors Collaboration showing that C-reactive protein provides incremental risk information comparable to that of total cholesterol and HDL cholesterol.
August 26th, 2011
The Power of Zero on JUPITER
Anita Vashi, MD, MPH
This voluntary contribution from Dr. Nasir, the principal investigator of a recent study published in the Lancet, is an extension of his remarks in a recent panel discussion Background: The study showed that people with low LDL levels and high C-reactive protein levels may benefit from coronary artery calcium scans to identify the folks who are most likely to […]
August 22nd, 2011
Panel: Coronary Calcium vs. CRP for Predicting Cardiovascular Events
CardioExchange Editors, Staff
Drs. Paul Ridker and Sanjay Kaul offer their perspectives on a new coronary artery calcium/C-reactive protein study, published in the Lancet, and three of the study authors respond. The study showed that people with low LDL levels and high CRP levels may benefit from CAC scans to identify the folks who are most likely to […]